Joni Kahn bought $10k of BLIN
director at Bridgeline Digital, Inc.. 6,579 shares at an average of $1.52, traded Mar 26, 2025, filed Mar 28, 2025.
Score components
- +15RoleDirector
- 0Trade size$10k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-25-009838, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 26, 2025 | POpen-market purchase Common Stock (BLIN)indirect: By James Weil and Joni Kahn 2004 Living Trust | +6,579 | $1.52 | $10k | 6,579 | Mar 28, 2025 |
Related signals
Other insiders at Bridgeline Digital, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | Bridgeline Digital, Inc. | Michael Ketslakh director | $600k 394,736 shares | - | |
| 47Moderate | Bridgeline Digital, Inc. | Roger E. Kahn President and CEO | $51k 33,334 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.